Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Muhammad K. Nisar"'
Autor:
Peter C. Taylor, Ayman Askari, Ernest Choy, Michael R. Ehrenstein, Sara Else, Muhammad K. Nisar
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background Rheumatoid arthritis (RA) is a chronic inflammatory disease that is associated with joint pain and stiffness. Biologics represent some of the most effective treatments for RA, but previous guidance from the National Institute for
Externí odkaz:
https://doaj.org/article/7b0471b44dda43c790c34ef8738fd283
Publikováno v:
European Journal of Rheumatology, Vol 7, Iss 1, Pp 21-25 (2020)
Externí odkaz:
https://doaj.org/article/bff11cfe109e453489abf11933f39408
Autor:
Muhammad K. Nisar
Publikováno v:
European Journal of Rheumatology, Vol 6, Iss 1, Pp 60-61 (2019)
Externí odkaz:
https://doaj.org/article/4a0c384be34443449bf8a3cd6da31c53
Publikováno v:
Mediterranean Journal of Rheumatology
Mediterranean Journal of Rheumatology, Vol 31, Iss 4, Pp 393-399 (2020)
Mediterranean Journal of Rheumatology, Vol 31, Iss 4, Pp 393-399 (2020)
Background/Objectives: The presence of bony erosions in patients with RA is a marker of disease severity and once present they are largely irreversible. Previous studies have shown that the presence of both rheumatoid factor (RF) and anti-cyclic citr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37950848a5c1ea51ad05d5ab0f6006f2
http://europepmc.org/articles/PMC7841098
http://europepmc.org/articles/PMC7841098
Autor:
Julie Begum, Muhammad K Nisar
Publikováno v:
Rheumatology. 61
Background/Aims Centralised phlebotomy services have been an integral part of providing blood monitoring facility for people with chronic diseases prescribed vital therapies. However, the patient experience is not always optimal due to the issues of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49f7b241d2ae79e20e59d8f69a454e28
https://doi.org/10.1093/rheumatology/keac133.117
https://doi.org/10.1093/rheumatology/keac133.117
Publikováno v:
Mediterranean Journal of Rheumatology, Vol 30, Iss 4, Pp 224-227 (2019)
Mediterranean Journal of Rheumatology
Mediterranean Journal of Rheumatology
A 68-year-old gentleman presented to hepatology department with asymptomatic year-long history of stably deranged liver function tests. His peak alkaline phosphatase (ALP), was 828 with alanine transaminase (ALT) of 141. Full liver workup was negativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ed587a295195a882a942efaacd231d
http://www.mjrheum.org/assets/files/792/file200_1062.pdf
http://www.mjrheum.org/assets/files/792/file200_1062.pdf
Autor:
Michael Y. Henein, Giulia Elena Mandoli, Maria Concetta Pastore, Nicolò Ghionzoli, Fouhad Hasson, Muhammad K. Nisar, Mohammed Islam, Francesco Bandera, Massimiliano M. Marrocco-Trischitta, Irene Baroni, Alessandro Malagoli, Luca Rossi, Andrea Biagi, Rodolfo Citro, Michele Ciccarelli, Angelo Silverio, Giulia Biagioni, Joseph A. Moutiris, Federico Vancheri, Giovanni Mazzola, Giulio Geraci, Liza Thomas, Mikhail Altman, John Pernow, Mona Ahmed, Ciro Santoro, Roberta Esposito, Guillem Casas, Rubén Fernández-Galera, Maribel Gonzalez, Jose Rodriguez Palomares, Ibadete Bytyçi, Frank Lloyd Dini, Paolo Cameli, Federico Franchi, Gani Bajraktari, Luigi Paolo Badano, Matteo Cameli
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5863, p 5863 (2021)
Scientia
Journal of Clinical Medicine; Volume 10; Issue 24; Pages: 5863
Journal of Clinical Medicine
Scientia
Journal of Clinical Medicine; Volume 10; Issue 24; Pages: 5863
Journal of Clinical Medicine
COVID-19; Biomarkers; Creatinine COVID-19; Biomarcadores; Creatinina COVID-19; Biomarcadors; Creatinina Background: The COVID-19 pandemic carries a high burden of morbidity and mortality worldwide. We aimed to identify possible predictors of in-hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902d04db020d31dff77c9dde2122a186
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-190815
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-190815
Autor:
Issrah Jawad, Muhammad K Nisar
Publikováno v:
Rheumatology. 59
Background NICE guidelines recommend the first line use of DMARDs in psoriatic arthritis (PsA). However, studies show that many conventional treatments like methotrexate are poorly tolerated. There is hitherto no published real-world data addressing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cef71c2d93601d9d6cf45f467262458
https://doi.org/10.1093/rheumatology/keaa111.265
https://doi.org/10.1093/rheumatology/keaa111.265
Publikováno v:
Rheumatology. 59
Background Specialist services are heavily reliant on a consultant reviewing a patient and discussing management options. We designed an innovative proof-of-concept osteoporosis service with patients only consulting a metabolic bone CNS and a consult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::721d7929045f4dad250f41fdfb8d5c74
https://doi.org/10.1093/rheumatology/keaa111.087
https://doi.org/10.1093/rheumatology/keaa111.087
Publikováno v:
Rheumatology. 59
Background Teriparatide is an effective treatment option for osteoporosis, however NICE restricts its use to patients with a high disease burden. This was based on a cost effectiveness evaluation of the originator (Forsteo®) and would be different f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85d43f181b611f43d45492e7a131bdd1
https://doi.org/10.1093/rheumatology/keaa109.021
https://doi.org/10.1093/rheumatology/keaa109.021